As assessed by qPCR, imatinib was found to down regulate expression of Hsp32 mRNA in the Ph+ ALL cell lines TOM-1 and NALM-1 (Figure 2A). This evidence concerns the gene HMOX1 and acute lymphoblastic leukemia.